» Articles » PMID: 7543437

Enhanced Nitric Oxide Synthase Activity in Portal Hypertensive Rabbits

Overview
Journal Hepatology
Specialty Gastroenterology
Date 1995 Aug 1
PMID 7543437
Citations 15
Authors
Affiliations
Soon will be listed here.
Abstract

Portal hypertension (PHT) is characterized by splanchnic hyperemia caused by a reduction in mesenteric vascular resistance. Mediators of this hyperemia include nitric oxide (NO). This is based on several reports indicating a marked splanchnic hyporesponsiveness in PHT to vaso-constrictor stimuli, both in vitro and in vivo, and a subsequent reversal using specific inhibitors of NO synthase (NOS). The objective of this study was to determine directly if the generation of NO is altered in PHT vasculature. Thus, we compared NOS activity in the hyperemic vasculature of normal rabbits and rabbits with PHT (after undergoing partial portal vein ligation). Nicotinamide adenine dinucleotide phosphate diaphorase staining indicated the presence of NOS within the vascular endothelium. Ca(2+)-dependent NOS activity was significantly increased (P < .05) in PHT particulate fractions from the superior mesenteric artery and thoracic aorta, but not from the portal vein. There was no change in NOS activity within the cytosolic fractions. Arterial wall cyclic guanosine monophosphate (cGMP) levels and plasma nitrite levels were both significantly increased in PHT. These results show enhanced NOS activity in PHT hyperemic vessels concurrent with increased tissue cGMP levels. We conclude that enhanced NO synthesis contributes to the hyperdynamic circulation of PHT.

Citing Articles

The portal hypertension syndrome: etiology, classification, relevance, and animal models.

Bosch J, Iwakiri Y Hepatol Int. 2017; 12(Suppl 1):1-10.

PMID: 29064029 DOI: 10.1007/s12072-017-9827-9.


Overproduction of nitric oxide inhibits vascular reactivity in portal hypertensive rats.

Li X, Wu J, He Z, Ma Q, Gao D World J Gastroenterol. 2016; 3(4):221-4.

PMID: 27053869 PMC: 4806237. DOI: 10.3748/wjg.v3.i4.221.


Nitric oxide and prostaglandin as mediators in the pathogenesis of hyperkinetic circulatory state in a model of endotoxemia-induced portal hypertension.

Rizvi M, Tauseef M, Shahid M, Babbar R, Fahim M, Sakhuja P Hepatol Int. 2015; 7(2):622-35.

PMID: 26201795 DOI: 10.1007/s12072-012-9397-9.


Hepatosplanchnic circulation in cirrhosis and sepsis.

Prin M, Bakker J, Wagener G World J Gastroenterol. 2015; 21(9):2582-92.

PMID: 25759525 PMC: 4351207. DOI: 10.3748/wjg.v21.i9.2582.


Hemodynamic and antifibrotic effects of a selective liver nitric oxide donor V-PYRRO/NO in bile duct ligated rats.

Moal F, Veal N, Vuillemin E, Barriere E, Wang J, Fizanne L World J Gastroenterol. 2006; 12(41):6639-45.

PMID: 17075977 PMC: 4125669. DOI: 10.3748/wjg.v12.i41.6639.